RGLD vs. RIGL
RGLD (Royal Gold, Inc.) and RIGL (Rigel Pharmaceuticals, Inc.) are both stocks. RGLD operates in Gold (Basic Materials), while RIGL operates in Biotechnology (Healthcare). Over the past 10 years, RGLD returned 13.61%/yr vs 3.28%/yr for RIGL. At a 0.09 correlation, their price movements are largely independent.
Performance
RGLD vs. RIGL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RGLD achieves a -6.25% return, which is significantly higher than RIGL's -23.30% return. Over the past 10 years, RGLD has outperformed RIGL with an annualized return of 13.61%, while RIGL has yielded a comparatively lower 3.28% annualized return.
RGLD
- 1D
- 1.47%
- 1M
- -15.27%
- YTD
- -6.25%
- 6M
- -4.74%
- 1Y
- 16.96%
- 3Y*
- 21.73%
- 5Y*
- 12.37%
- 10Y*
- 13.61%
RIGL
- 1D
- 2.40%
- 1M
- 2.24%
- YTD
- -23.30%
- 6M
- -19.45%
- 1Y
- 54.23%
- 3Y*
- 27.10%
- 5Y*
- -3.96%
- 10Y*
- 3.28%
RGLD vs. RIGL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RGLD Royal Gold, Inc. | -6.25% | 70.43% | 10.39% | 8.70% | 8.51% | 0.04% | -12.13% | 44.27% | 5.53% | 31.32% |
RIGL Rigel Pharmaceuticals, Inc. | -23.30% | 154.64% | 16.00% | -3.33% | -43.40% | -24.29% | 63.55% | -6.96% | -40.72% | 63.03% |
Correlation
The correlation between RGLD and RIGL is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.12 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Nov 29, 2000 | 0.09 |
Fundamentals
RGLD:
$17.65B
RIGL:
$646.69M
RGLD:
$8.53
RIGL:
$19.21
RGLD:
24.34
RIGL:
1.71
RGLD:
1.66
RIGL:
0.00
RGLD:
11.81
RIGL:
2.08
RGLD:
2.38
RIGL:
1.62
RGLD:
$1.31B
RIGL:
$299.77M
RGLD:
$579.68M
RIGL:
$279.95M
RGLD:
$949.59M
RIGL:
$125.80M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RGLD vs. RIGL — Risk / Return Rank
RGLD
RIGL
RGLD vs. RIGL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Royal Gold, Inc. (RGLD) and Rigel Pharmaceuticals, Inc. (RIGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RGLD | RIGL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.35 | ||
| Sortino ratioReturn per unit of downside risk | -0.83 | ||
| Omega ratioGain probability vs. loss probability | 1.11 | 1.20 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 0.48 | 1.09 | -0.60 |
| Martin ratioReturn relative to average drawdown | 1.27 | 1.91 | -0.63 |
Loading charts...
Drawdowns
RGLD vs. RIGL - Drawdown Comparison
The maximum RGLD drawdown since its inception was -98.29%, roughly equal to the maximum RIGL drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for RGLD and RIGL.
Loading charts...
Drawdown Indicators
| RGLD | RIGL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.29% | -99.37% | +1.08% |
Max Drawdown (1Y)Largest decline over 1 year | -35.12% | -50.08% | +14.96% |
Max Drawdown (3Y)Largest decline over 3 years | -35.12% | -57.75% | +22.63% |
Max Drawdown (5Y)Largest decline over 5 years | -40.73% | -85.24% | +44.51% |
Max Drawdown (10Y)Largest decline over 10 years | -49.55% | -86.40% | +36.85% |
Current DrawdownCurrent decline from peak | -31.66% | -96.93% | +65.27% |
Average DrawdownAverage peak-to-trough decline | -29.82% | -90.91% | +61.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.34% | 28.64% | -15.30% |
Volatility
RGLD vs. RIGL - Volatility Comparison
Royal Gold, Inc. (RGLD) and Rigel Pharmaceuticals, Inc. (RIGL) have volatilities of 12.33% and 12.05%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RGLD | RIGL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.33% | 12.05% | +0.28% |
Volatility (6M)Calculated over the trailing 6-month period | 32.22% | 36.64% | -4.42% |
Volatility (1Y)Calculated over the trailing 1-year period | 39.34% | 69.89% | -30.55% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.58% | 85.46% | -53.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.66% | 82.81% | -49.15% |
Dividends
RGLD vs. RIGL - Dividend Comparison
RGLD's dividend yield for the trailing twelve months is around 0.89%, while RIGL has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RGLD Royal Gold, Inc. | 0.89% | 0.81% | 1.21% | 1.24% | 1.24% | 1.14% | 1.05% | 0.87% | 1.17% | 1.17% | 1.45% | 1.81% |
RIGL Rigel Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
RGLD vs. RIGL - Financials Comparison
This section allows you to compare key financial metrics between Royal Gold, Inc. and Rigel Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RGLD vs. RIGL - Profitability Comparison
RGLD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Royal Gold, Inc. reported a gross profit of 0.00 and revenue of 469.13M. Therefore, the gross margin over that period was 0.0%.
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.
RGLD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Royal Gold, Inc. reported an operating income of 297.09M and revenue of 469.13M, resulting in an operating margin of 63.3%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.
RGLD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Royal Gold, Inc. reported a net income of 281.13M and revenue of 469.13M, resulting in a net margin of 59.9%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.
Frequently Asked Questions
RGLD and RIGL have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RGLD has higher volatility (12.33%) compared to RIGL (12.05%). In terms of maximum drawdown, RGLD dropped -98.29% vs RIGL's -99.37%.
RIGL currently has the higher Sharpe Ratio (0.78 vs 0.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RGLD and RIGL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer